logo:CUMC

icon_print

Class of 1981

Ron Cohen was appointed to the Board of Directors of Dyax Corp., which develops biotherapeutics, and will serve on the compensation committee of the board. Read the announcement here. Dr. Cohen is founder, president, and CEO of Acorda Therapeutics.